Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 77/100

Tandem Diabetes Care Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript

Sep 22, 2021 / 08:35PM GMT
Release Date Price: €105.4 (+0.81%)
Steven Michael Lichtman
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

Hi, everyone. This is Steve Lichtman, Medical Devices Analyst at Oppenheimer. Welcome back to the Oppenheimer Fall Healthcare summit. Very happy to have with us up next Tandem Diabetes, a leader in the insulin pump market. With us today are John Sheridan, President and CEO; Susan Morrison, EVP and CIO, and Liz Gasser, EVP and Chief Strategy Officer. This will be a fireside format. If you have any questions, please submit them, and I'll get them over to the management team. I am going to turn it over to John for a few opening comments. And then again, we'll go right into questions. Thanks John.

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Sure. Steve, it's great to be here. It's good to see you. We're looking forward to these meetings being in person in the future. I just want to start off by saying that we are continuing to see great momentum with Control-IQ in the market. And in the US, it's been in the market now for approximately

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot